Homepage SISA Lombardia

CONVEGNO MONOTEMATICO SIF
NUOVE FRONTIERE NELLA TERAPIA
DELL’ATEROSCLEROSI

Milano, 3 Febbraio 2012


Programma


Apolipoprotein CIII: 42 years old and even more interesting
ATVB 2011;31:471-3 - Abstract e diapositive


Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia

ATVB 2011;31:513-9 - Abstract e diapositive


Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial

Circulation 2011;124:555-562 - Abstract e diapositive

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
N Engl J Med 2011;364:127-35 - Abstract e diapositive

Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes
NMCD 2011;21:79-85 - Abstract e diapositive